Quick Takeaways
- J. WOOD CAPITAL ADVISORS LLC filed SCHEDULE 13G/A for Karyopharm Therapeutics Inc. Common Stock, $0.0001 par value (KPTI).
- Disclosed ownership: 5%.
- Date of event: 14 Oct 2025.
J. WOOD CAPITAL ADVISORS LLC - 14 Oct 2025 SCHEDULE 13G/A Report for Karyopharm Therapeutics Inc. Common Stock, $0.0001 par value (KPTI)
- Filing Manager
- J. WOOD CAPITAL ADVISORS LLC
- Reporting Manager
- J. Wood Capital Advisors LLC
- Symbol
- KPTI
- Shares outstanding
- 20,054,269 shares
- Disclosed Ownership
- 1,000,708 shares
- Ownership
- 5%
- Form type
- SCHEDULE 13G/A
- Filing time
- 03 Nov 2025, 16:30:16 UTC
- Date of event
- 14 Oct 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"J. WOOD CAPITAL ADVISORS LLC disclosed 5% ownership in Karyopharm Therapeutics Inc. Common Stock, $0.0001 par value (KPTI) on 14 Oct 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 03 Nov 2025, 16:30.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| J. Wood Capital Advisors LLC | 5% | 1,000,708 | 0 | 1,000,708 | /s/ Jason Wood | Jason Wood, Chief Executive Officer | |
| Jason Wood | 5% | 1,000,708 | 0 | 1,000,708 | /s/ Jason Wood | Jason Wood |